FAS and breast cancer: The quantity of CTCs correlates with the presence in peripheral blood of the CD95(FAS)-positive T-helper cells and stage 3 breast cancer as well as with lower percentage of the CD8+ T-cells with activated T-cell receptor (52, 53), the absence of tumor associated antigen specific TCRs and low TCR heterogeneity (54), and positively associated with intratumoral populations of T-regs (55).